Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine PlatformGlobeNewsWire • 01/07/24
Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 OutlookGlobeNewsWire • 01/07/24
Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics WorkflowGlobeNewsWire • 01/07/24
How Akoya Biosciences (AKYA) Stock Stands Out in a Strong IndustryZacks Investment Research • 01/05/24
How Much Upside is Left in Akoya (AKYA)? Wall Street Analysts Think 86%Zacks Investment Research • 12/27/23
Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue GuidanceGlobeNewsWire • 11/08/23
Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023GlobeNewsWire • 10/31/23
Akoya Biosciences Announces Peer-Reviewed Publication Using Ultrahigh-Plex Spatial Phenotyping of Head and Neck Cancer to Identify Distinct Immune and Metabolic SignaturesGlobeNewsWire • 10/17/23
Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 PlatformsGlobeNewsWire • 09/19/23
Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue GuidanceGlobeNewsWire • 08/07/23
Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology TechnologiesGlobeNewsWire • 08/07/23
Can Akoya (AKYA) Climb 116.14% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 07/12/23